Eden and Ozempic: Branded vs Compounded Semaglutide

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

Independent editorial review. PlexusDx has no commercial relationship with Eden, with the maker of Ozempic, or with any brand referenced here, and publishes no affiliate links.

Full head-to-head: PlexusDx vs Eden →

A search for Ozempic often lands on telehealth pages like Eden’s, where the product is usually compounded semaglutide rather than the branded drug. This review separates the two, explains how Eden prices its semaglutide pathway, and points to the evidence behind the compound. Fair-balance framing, not a buying recommendation. Updated July 2026.

Ozempic, semaglutide, and where Eden fits

Ozempic is a brand name for semaglutide, a GLP-1 receptor agonist approved by the FDA. Eden does not brand a product like Ozempic; it is a telehealth service that, after a licensed provider reviews intake, routes a prescription to a 503A compounding pharmacy for compounded semaglutide or to a retail pharmacy for an FDA-approved brand. Check Eden’s official website for what it dispenses.

Branded Ozempic versus compounded semaglutide

The molecule at issue is semaglutide in both cases, but branded Ozempic is FDA-approved and manufactured to that standard, whereas compounded semaglutide is prepared patient-specifically at a 503A pharmacy and is not FDA-approved in the same sense. Telehealth programs generally offer the compounded route, and understanding that difference is essential before you order.

How Eden prices its semaglutide pathway

Eden advertises $99/month for compounded semaglutide as medication only, but an active membership at $99/month (disclosed in a footnote) is required to dispense, so the true recurring cost is $198 all-in, with nothing charged until a provider approves. Eden bills monthly, dispenses injections only, and adds a money-back warranty tied to losing 10% of body weight in six months. Eden figures verified at checkout, July 2026.

What the semaglutide trials showed

Semaglutide’s weight-management evidence comes principally from the STEP program (The New England Journal of Medicine, 2021), part of the broader GLP-1 receptor agonist class that also includes liraglutide and dulaglutide. Trial populations and endpoints varied across studies, and individual outcomes differ, whether the semaglutide dispensed is a branded product or a compounded formulation.

It is worth being precise about what those trials tested: the branded, FDA-approved semaglutide product under controlled study conditions. A compounded preparation carries the same active molecule but was not the exact formulation evaluated, so the published data speak to the compound rather than to any one compounded batch. That distinction belongs in the conversation with your clinician.

The semaglutide response your prescription cannot see

Branded or compounded, the prescription is blind to the biology it enters. Variants in GLP1R, the receptor gene semaglutide targets, along with FTO, MC4R, and TCF7L2, describe the metabolic baseline that shapes appetite regulation and energy balance. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights across them. It does not predict semaglutide response, but it informs the conversation. PlexusDx offers semaglutide via its Weight Management Protocols as Semaglutide Injection ($189/month) and Semaglutide Oral ($289/month).

Not affiliated: PlexusDx is not affiliated with Eden or with the maker of Ozempic and has no commercial relationship with the companies reviewed here.

Related reading on PlexusDx: How To Get Ozempic, Mounjaro vs Ozempic, Ozempic Cost, Ozempic For Diabetes.

Disclaimer: This article is educational. PlexusDx is not affiliated with Eden or the manufacturer of Ozempic and has no commercial relationship with the companies reviewed. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

See how PlexusDx approaches the semaglutide pathway: the Weight Management Protocols, or start with the Precision Peptide Genetic Test.

Frequently Asked Questions

Does Eden prescribe Ozempic?

Eden is a telehealth program rather than a brand, and typically dispenses compounded semaglutide instead of branded Ozempic. Whether an FDA-approved brand is available depends on the prescription a licensed provider writes and the pharmacy pathway used. Confirm the specific product on Eden’s own site before ordering.

Is compounded semaglutide the same as Ozempic?

Both contain semaglutide, but branded Ozempic is FDA-approved and manufactured to that standard, while compounded semaglutide is prepared patient-specifically at a 503A pharmacy and is not FDA-approved in the same way. The active molecule is shared; the regulatory status and sourcing are not.

How much does Eden’s semaglutide cost?

Eden lists $99/month for compounded semaglutide as medication only, but a required $99 membership brings the true recurring total to $198, with no charge until a provider approves. Billing is monthly and injections only, verified at checkout July 2026.

How does PlexusDx approach semaglutide differently?

PlexusDx offers Semaglutide Injection at $189 and Semaglutide Oral at $289 month to month, with no membership gate, and pairs them with the Precision Peptide Genetic Test for upstream pathway context. That genetic layer, absent from most telehealth-only programs, is the core difference in approach.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education